Clinical trial Recruiting at 1 site Interventional Ages 18 to 43 Women only

Preventing bleeding during myomectomy with misoprostol

Official title: Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.

Run by University Hospital, Clermont-Ferrand · NCT06882824 · Data updated 2026-11-12

This will test whether giving misoprostol before myomectomy reduces surgical bleeding in women aged 18–43 having surgery for symptomatic uterine fibroids.

Quick facts

Study typeInterventional
Ages18 Years to 43 Years
SexWomen only
Enrollment80 (estimated)
SponsorUniversity Hospital, Clermont-Ferrand
Academic / other
Locations1 site (Clermont-Ferrand, Clermont-Ferrand)
StatusRecruiting
StartedMarch 12, 2025
Main results expectedApril 17, 2027
Study endsApril 17, 2028
Registry record updatedSeptember 24, 2025
Trial IDNCT06882824 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–43 with symptomatic uterine fibroids scheduled for laparoscopic or open myomectomy who meet the protocol size/number criteria, speak French, and are covered by a French social security scheme.

Probably not a fit

Patients on anticoagulants, with haemostatic disorders, pregnancy or breastfeeding, prior major uterine surgery, hepatic or renal insufficiency, or allergy to misoprostol are excluded and unlikely to receive benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial at CHU Clermont-Ferrand compares misoprostol versus placebo given before myomectomy to reduce intraoperative blood loss. Eligible women are 18–43 with symptomatic fibroids and an indication for laparoscopic or open myomectomy according to size and number criteria in the protocol. Participants receive misoprostol or placebo perioperatively and investigators record surgical blood loss, hemoglobin change, and transfusion needs. Key exclusions include anticoagulant use, bleeding disorders, prior major uterine surgery, pregnancy or hypersensitivity to misoprostol.

Why it matters

Potential benefit: If effective, misoprostol could lower intraoperative blood loss, reduce transfusion rates, and help patients recover faster after myomectomy.

How similar studies have gone: Small studies and clinical use of misoprostol for uterine contraction have suggested it may reduce surgical bleeding, but robust high-quality evidence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient aged 18 to 43
* Symptomatic myomas (bleeding, pain or infertility)
* Indication for laparoscopic myomectomy Fibroma ≤ 10cm or number ≤ to 4 fibroids
* Indication for myomectomy by laparotomy Fibroma \> 10cm, Number \> to 4 fibroids
* OTAU possible intraoperatively (Clip on uterine artery and tourniquet placement)
* Speak and understand French
* Affiliated with a social security scheme.

Exclusion Criteria:

* History of major uterine surgery or myomectomy (excluding hysteroscopic myomectomy)
* Allergy to misoprostol and lactose
* Patients with hypersensitivity to misoprostol and/or other prostaglandins or to any of the product's excipients.
* Patients taking aspirin or anti-coagulants
* Patients with haemostasis disorders
* Malnourished patients
* Patients with hepatic or renal insufficiency
* Pregnancy, suspected ectopic pregnancy and breast-feeding women.
* Minors
* Guardianship, curatorship, deprived of liberty, safeguard of justice

Where it's running

  • CHU Clermont-Ferrand
    Clermont-Ferrand, Clermont-Ferrand, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.